Bank Julius Baer & Co
DXCM icon

Bank Julius Baer & Co’s DexCom DXCM Stock Holding History

Bank Julius Baer & Co’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
34,630
+4,764
+16% +$317K 0.01% 321
2026
Q1 		$1.85M Sell
29,866
-7,276
-20% -$507K 0.01% 323
2025
Q4 		$2.49M Sell
37,142
-98,913
-73% -$6.39M 0.01% 299
2025
Q3 		$9.16M Buy
136,055
+52,949
+64% +$4.19M 0.03% 201
2025
Q2 		$7.25M Sell
83,106
-5,866
-7% -$460K 0.02% 207
2025
Q1 		$6.05M Sell
88,972
-3,499
-4% -$286K 0.02% 233
2024
Q4 		$7.49M Sell
92,471
-1,369
-1% -$101K 0.02% 224
2024
Q3 		$6.73M Sell
93,840
-6,822
-7% -$560K 0.02% 214
2024
Q2 		$11.9M Sell
100,662
-7,653
-7% -$968K 0.05% 149
2024
Q1 		$15.1M Sell
108,315
-1,062
-1% -$133K 0.06% 150
2023
Q4 		$13.6M Buy
109,377
+61,723
+130% +$6.31M 0.06% 163
2023
Q3 		$4.45M Buy
47,654
+332
+0.7% +$37.4K 0.03% 182
2023
Q2 		$6.08M Buy
47,322
+13,849
+41% +$1.67M 0.04% 173
2023
Q1 		$3.89M Sell
33,473
-3,174
-9% -$355K 0.02% 190
2022
Q4 		$4.15M Buy
36,647
+42
+0.1% +$4.61K 0.03% 185
2022
Q3 		$2.95M Buy
36,605
+216
+0.6% +$18.3K 0.02% 183
2022
Q2 		$2.71M Buy
36,389
+601
+2% +$54.9K 0.02% 193
2022
Q1 		$4.58M Buy
35,788
+2,684
+8% +$294K 0.03% 177
2021
Q4 		$4.44M Buy
33,104
+4,160
+14% +$598K 0.02% 211
2021
Q3 		$3.96M Buy
28,944
+4,796
+20% +$605K 0.02% 208
2021
Q2 		$2.58M Sell
24,148
-5,012
-17% -$481K 0.02% 256
2021
Q1 		$2.62M Buy
29,160
+10,604
+57% +$995K 0.02% 245
2020
Q4 		$1.72M Buy
18,556
+10,900
+142% +$973K 0.01% 275
2020
Q3 		$789K Buy
+7,656
New +$800K 0.01% 320

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank Julius Baer & Co's DXCM Position: Q2 2026 in Review

Bank Julius Baer & Co increased its DexCom (DXCM) stake by 16% in Q2 2026, buying an estimated $317K and bringing the position to 34,630 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #321.

Bank Julius Baer & Co first reported a position in DXCM in Q3 2020 and has held it in 24 quarters since. The position peaked at $15.1M in Q1 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bank Julius Baer & Co held 34,630 shares of DexCom worth $2.34M as of Q2 2026.
  • Bank Julius Baer & Co bought 4,764 DexCom shares in Q2 2026, an estimated $317K.
  • DexCom made up 0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #321 holding.
  • Bank Julius Baer & Co first reported a position in DexCom in Q3 2020 and has held it in 24 quarters since.
  • Bank Julius Baer & Co's DexCom position peaked at $15.1M in Q1 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.